Fubitai｜Fanyi Kong’s first death after inoculation of Fubitai in Hong Kong is not directly related to the vaccine

Social News

Written by: Huang Yongyu

2021-03-24 12:13

Last update date: 2021-03-24 12:15

The first case of death after vaccination with Forbitux vaccination occurred in Hong Kong earlier. The co-convenor of the New Coronary Vaccine Clinical Events Evaluation Expert Committee and the clinical professor of the Department of Internal Medicine of the University of Hong Kong, Kong Fanyi, told the RTHK program today (24) that the committee will meet to discuss the case. It is initially known that the deceased had chronic illnesses, three highs and smoking habits during his lifetime, and it is expected that there is no direct relationship with vaccination.

Kong Fanyi said that after the meeting of the expert group, it was believed that the existing data could rule out cases directly related to Kexing Vaccine.

(Photo by Zhang Haowei)

Kong Fanyi said that the University of Hong Kong is currently recruiting 50 to 100 healthy people aged 18 to 60 to participate in the mixed vaccination study.

Under the plan, participants will be injected with Fubitai vaccine first, followed by Kexing vaccine. The Hong Kong Congress will regularly draw blood for them to understand their antibody levels and compare the relevant data.

Regarding whether "groove injection" will aggravate side effects, he said that there are scientific reasons to believe that antibodies and protective effects will be better. In addition, the research subjects are young and healthy people. Both vaccines are safe. I believe "groove injection" Does not enhance side effects.

Fubitai｜The Hong Kong government suspends vaccination. This morning, more than 100 people in the center have already given injections. Macau takes the lead in suspending the vaccination

Fubitai | News: Hong Kong suspends BioNTech vaccination, Macau Health Bureau says vaccine packaging is defective

New Crown Vaccine | 20 people sent to hospital after vaccination to recover Bitai's 20-year-old female unconscious, 28-year-old male fainted

01News

New Crown Vaccine New Crown Pneumonia BioNTech/Fosun Vaccine